BetterLife Pharma BETRF Cash Flow Statement (2010-2026)

OTC BETRF
$0.22 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

BetterLife Pharma Quarterly Cash Flow Statement

Periods 62 quarters
Latest Apr 2026

BetterLife Pharma reported cash from operations of -$0.17M and free cash flow of -$0.17M for the quarter ended Apr 2026. This cash flow statement covers 62 quarters of results from Oct 2010 through Apr 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Jan2012 Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Jan2026 Apr2026
Operating Activities
Net Income
-1.94M-2.91M-1.76M-3.11M-2.36M-0.87M-3.52M-0.43M-0.71M-0.77M-0.16M-0.51M-1.51M-1.06M0.47M-0.54M-0.15M-0.37M-0.45M
Share-based CompensationStock Comp.
0.17M0.16M0.14M0.51M0.31M0.20M0.11M0.12M0.07M0.17M0.08M0.05M1.20M0.02M0.17M0.12M0.05M0.03M0.11M
Cash from Discontinued OperationsCash from Discont. Ops
-2.27M-3.47M-1.69M-0.32M-0.25M-1.12M-1.00M-0.35M-0.13M-0.63M-0.73M-0.01M-0.13M-0.17M
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
0.03M0.10M0.03M0.02M0.15M-0.19M0.05M-0.07M0.12M-0.00M0.06M0.05M-0.00M-0.08M-0.02M-0.05M0.01M
Asset Writedowns and ImpairmentWritedown
Cash from OperationsCash from Ops.
-2.27M-3.47M-1.69M-1.54M-0.32M-0.25M-0.48M-0.10M-1.00M-0.35M-0.29M0.00M-0.63M-0.73M-0.10M-0.00M-0.01M-0.13M992.22-0.17M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.00M0.00M0.00M0.00M0.01M0.01M0.01M757.710.02M0.12M0.04M-0.06M0.02M0.01M0.00M
Depreciation & Amortization (CF)Dep. & Amort.
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Change in Working Capital
Change in ReceivablesChange Receivables
0.31M0.02M0.02M-0.20M0.25M-0.01M-0.01M0.01M-0.01M0.02M-664.48-0.02M0.01M-0.00M0.01M-0.00M0.00M-280.93-0.00M
Change in InventoryChange Inventory
Change in Account PayablesChange Payables
-0.06M-0.22M-0.14M0.01M0.14M0.10M0.21M-0.09M0.35M0.09M0.16M0.32M0.02M-0.03M0.17M0.25M0.26M0.27M0.13M
Change in Accured ExpensesChange Accured Exp.
-0.31M-0.39M-0.28M0.05M1.12M0.07M-0.22M0.73M-0.55M0.05M0.05M-0.06M-0.33M0.11M-0.35M0.62M0.03M0.01M0.00M
Change in TaxesChange Taxes
-0.13M
Investing Activities
Capital ExpendituresCapex
Acquisitions
Divestments
Cash from Investing ActivitiesCash from Investing
Financing Activities
Other financing activitiesOther financing
0.02M
Cash from Financing ActivitiesCash from Financing
2.39M6.70M120.880.20M0.25M1.30M-0.72M1.18M0.21M0.32M0.15M0.92M0.51M0.03M0.00M0.02M0.13M-324.260.19M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
1.95M7.31M112.190.12M0.23M1.18M0.16M0.21M0.07M0.19M
Additional items
Exchange Rate EffectFX Effect
0.07M-0.00M0.00M-0.01M-0.01M-0.01M-0.03M0.00M-0.01M0.01M-0.02M-31.81-0.02M482.74682.490.70-850.30534.920.720.00M
Change in Cash
0.10M3.23M-1.68M-1.55M-0.13M6.220.18M-0.18M0.18M-0.14M0.02M0.00M0.28M-0.22M-0.08M-138.070.01M0.00M668.690.01M
Beginning Cash Balance
0.12M0.13M0.12M0.12M0.14M0.13M0.13M0.13M0.01M0.01M0.01M0.01M0.03M0.03M0.03M0.03M0.01M0.01M0.01M0.01M
Free Cash FlowFCF
-2.27M-3.47M-1.69M-1.54M-0.32M-0.25M-0.48M-0.10M-1.00M-0.35M-0.29M0.00M-0.63M-0.73M-0.10M-0.00M-0.01M-0.13M992.22-0.17M
Net Cash FlowNCF
0.11M3.23M-1.69M-1.54M-0.12M-0.00M0.82M-0.82M0.18M-0.14M0.02M0.15M0.28M-0.22M-0.08M-138.770.01M0.00M667.970.01M